Zobrazeno 1 - 10
of 83
pro vyhledávání: '"farhad shahi"'
Autor:
Mohammad Reza Eskandarion, Sharareh Eskandarieh, Abbas Shakoori Farahani, Habibollah Mahmoodzadeh, Farhad Shahi, Mohammad Ali Oghabian, Reza Shirkoohi
Publikováno v:
Heliyon, Vol 10, Iss 9, Pp e30253- (2024)
Background & aim: The histologic and molecular changes from intestinal metaplasia (IM) to gastric cancer (GC) have not been fully characterized. The present study sought to identify potential alterations in signaling pathways in IM and GC to predict
Externí odkaz:
https://doaj.org/article/709130d95bda45108c3dae2d37623867
Autor:
Alborz Sherafati, Mehrzad Rahmanian, Roya Sattarzadeh Badkoubeh, Meysam Khoshavi, Morteza Foroumandi, Soheil Peiman, Farhad Shahi, Akram Sardari, Roghayeh Pourkia, Farnoosh Larti
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-6 (2023)
Abstract Background Nearly half of the patients with hypereosinophilic syndrome (HES) have cardiovascular involvement, a major cause of mortality. COVID-19 infection can lead to cardiac involvement, negatively impacting the clinical course and progno
Externí odkaz:
https://doaj.org/article/d0422584b0374eb38e8640d181e12a5e
Autor:
Abolghasem Allahyari, Ali Ehsanpour, Nafiseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kafi, Safa Najafi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Breast cancer is the most frequently diagnosed cancer and the leading reason for cancer-related death among women. Neoadjuvant treatment with dual-HER2 (human epidermal growth factor receptor 2) blockade has shown promising effect
Externí odkaz:
https://doaj.org/article/6c0bdcd3857a489a9e4632e013af9f15
Publikováno v:
Basic & Clinical Cancer Research, Vol 14, Iss 2 (2023)
Abstract Objective: We aimed to investigate safety and efficacy of preoperative chemotherapy using EOX regime in patients with locally advanced gastric and GEJ cancer who were admitted at Imam-Khomeini Oncology clinic and Aram clinic. Method: We p
Externí odkaz:
https://doaj.org/article/717176c365844f97a83164674861626a
Autor:
Reza Safaei Nodehi, Behjat Kalantari, Jahangir Raafat, Nafiseh Ansarinejad, Vahid Moazed, Seyed Mohammad Reza Mortazavizadeh, Mehran Hosseinzadeh, Bayazid Ghaderi, Arash Jenabian, Mojtaba Qadyani, Shirin Haghighat, Abolghasem Allahyari, Mehrzad Mirzania, Mohammad Seghatoleslami, Mehrdad Payandeh, Afsaneh Alikhasi, Hamidreza Kafi, Farhad Shahi
Publikováno v:
BMC Pharmacology and Toxicology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background This study compared efficacy and safety of TA4415V, a trastuzumab biosimilar, with reference trastuzumab in patients with human epidermal growth factor receptor 2–positive (HER2-positive) early-stage breast cancer treated in the
Externí odkaz:
https://doaj.org/article/90c12cf33ccd4cea98f2bc6387e4d2da
Autor:
Farhad Shahi, Reza Safaee, Saba Fekrvand, Fatemeh Fathi, Mohammad Reza Dabiri, Alireza Abdollahi, Hanieh Hosseini
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 17, Iss 2 (2023)
Background: Since 2019, Coronavirus has been a highly contagious disease. The COVID-19 outbreak was declared a pandemic by the World Health Organization in March 2020. Variable laboratory findings are reported in COVID-19 patients, among which elevat
Externí odkaz:
https://doaj.org/article/b549550115534de4b8b38f9e51597824
Autor:
Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kaf, Safa Najaf
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/93458d66b81745e385426b096fa0c6db
Publikováno v:
Case Reports in Clinical Practice, Vol 6, Iss S1 (2022)
Multiple myeloma (MM) has been suggested to associate with other solid tumors. Myeloma or its chemotherapy regimens may be a risk factor for developing primary and secondary malignancies. But the coexistence with other tumors is rare. We report an ol
Externí odkaz:
https://doaj.org/article/bb6dbcf6db5e4136863f4cb666a30c8c
Autor:
Mohammad Reza Salehi, Farhad Shahi, Fatema Sadaat Rizvi, Sara Ghaderkhani, Hamed Zainaldain, Sadegh Khodavaysi, Saeed Reza Jamali-Moghaddam, Seyed Ali Dehghan Manshadi, Omid Rezahosseini
Publikováno v:
Caspian Journal of Internal Medicine, Vol 11, Iss 2, Pp 227-230 (2020)
Background: Mucormycosis is an uncommon fungal infection caused by the members of the order Mucorales. In susceptible patients, mucormycosis can infect any tissue or organ, and without suitable treatment (i.e., debridement and antifungal therapy), th
Externí odkaz:
https://doaj.org/article/3fb54a1187a14089b0bf1cc567877564
Autor:
Farhad Shahi, Mojtaba Gorji, Assistant Professor of Pediatric Oncology, Mehrdad Payandeh, Assistant Professor of Hematology & Oncology, Hamid Rezvani, Associate Professor of Hematology & Oncology, Mohammad Vaezi, Associate Professor of Hematology & Oncology, Sharareh Seifi, Assistant Professor of Hematology & Oncology, Alireza Baari, Post doctoral fellowship, Reza Khalili-Dizaji, Post doctoral fellowship, Seyed Mehdi Hashemi, Associate Professor of Hematology & Oncology, Saeid Salimi, post doctoral fellowship, Hosein Kamranzadeh, Associate Professor of Hematology & Oncology, Babak Shazad, Post doctoral fellowship, Sina Salari, Associate Professor of Hematology & Oncology, Davoud Oulad Dameshghi, Assistant Professor of Hematology & Oncology, Mehdi Sarkheil, Post doctoral fellowship, Mehrzad Mirzania, Associate Professor of Hematology & Oncology, Nassim Anjidani, Pharm. D.
Publikováno v:
Current Therapeutic Research, Vol 96, Iss , Pp 100657- (2022)
ABSTRACT: Background: CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or me
Externí odkaz:
https://doaj.org/article/fe69c022b17c4466a61d792d92e624d0